Ruiz J, Egli M
Service d'endocrinologie, diabétologie et métabolisme CHUV, 101 Lausanne.
Rev Med Suisse. 2006 May 31;2(68):1480-2, 1484-5.
The Polypill: between myths and reality in the treatment of type 2 diabetes mellitus The concept of "Polypill" was developed from modeling analyses and the data were extracted from randomized-control trials and epidemiological studies. This "Polypill" should be a combination of three antihypertensive drugs associated to aspirin, a statin and folic acid. This "Polypill" would allow to reduce of more than 80% the cardiovascular events. The original publication suggests that all subjects of more than 55 years could benefit from this magic pill. Numerous positive and negative reactions showed themselves further to this publication. Other approaches based on the change of lifestyle seem so effective. Nevertheless, to have a really effective approach the therapeutic educational dimension should be also included in the basic strategy.
2型糖尿病治疗中的神话与现实 “复方制剂”的概念源于模型分析,数据提取自随机对照试验和流行病学研究。这种“复方制剂”应是三种降压药物与阿司匹林、一种他汀类药物和叶酸的组合。这种“复方制剂”可使心血管事件减少80%以上。最初的出版物表明,所有55岁以上的受试者都可能从这种神奇药丸中获益。该出版物发表后出现了许多正面和负面的反应。基于生活方式改变的其他方法似乎也很有效。然而,要想有真正有效的方法,治疗教育层面也应纳入基本策略。